Practitioner Perceptions of Attenuated Psychosis Syndrome

Overview

Journal Schizophr Res

Specialty Psychiatry

Date 2011 Jul 19

PMID 21764261

Citations 8

Authors

Elizabeth Jacobs

Emily Kline

Jason Schiffman

Affiliations

Soon will be listed here.

Abstract

The "Attenuated Psychosis Syndrome" (APS, sometimes referred to as the "schizophrenia prodrome") is characterized by subthreshold psychotic-like symptoms and functional decline, and is often associated with significant disability. These symptoms may cause impairment and are of further interest due to their predictive relation to schizophrenia and other psychotic disorders. These symptoms currently are not represented in the diagnostic system for mental health, and it is unclear how they are conceptualized by relevant professionals. The current study surveyed a national sample (n=303) of clinical psychologists, psychiatrists, and general practitioners regarding their clinical appraisal of APS. Practitioners were asked to respond to vignettes representing three conditions: psychosis, subthreshold psychosis (indicating 'attenuated' psychosis symptoms), and no psychotic symptoms. Practitioners' responses suggested that APS is viewed consistently with a DSM-IV-TR defined mental disorder and that most clinicians may diagnose this condition as a full threshold psychotic disorder. Findings tentatively suggest that the inclusion of an attenuated psychosis symptoms category in the forthcoming DSM-5 may be helpful in improving diagnostic reliability and facilitating best practice among community practitioners.

Citing Articles

Identifying individuals at risk of developing psychosis: A systematic review of the literature in primary care services.

Radez J, Waite F, Izon E, Johns L Early Interv Psychiatry. 2023; 17(5):429-446.

PMID: 36632681 PMC: 10946574. DOI: 10.1111/eip.13365.

Evaluating the tendencies of community practitioners who actively practice in child and adolescent psychiatry to diagnose and treat DSM-5 attenuated psychotic syndrome.

Yilmaz Kafali H, Solerdelcoll M, Vujinovic L, Martsenkovskyi D, Awhangansi S, Noel C Eur Child Adolesc Psychiatry. 2021; 31(10):1635-1644.

PMID: 34669043 DOI: 10.1007/s00787-021-01897-1.

Social work training to reduce duration of untreated psychosis: Methodology and considerations of a web-based training for community providers.

Andorko N, FitzGerald J, Roemer C, Solender E, Petti E, Rouhakhtar P Early Interv Psychiatry. 2021; 16(4):393-401.

PMID: 34031987 PMC: 8668167. DOI: 10.1111/eip.13178.

Considerations for the development and implementation of brief screening tools in the identification of early psychosis.

Schiffman J Schizophr Res. 2018; 199:41-43.

PMID: 29525462 PMC: 6128792. DOI: 10.1016/j.schres.2018.03.002.

School Counselors' Recognition of the Ultra-High Risk for Psychosis.

Lee J, Chung Y, Kim J, Shin I, Yoon J, Kim S Psychiatry Investig. 2018; 15(3):320-324.

PMID: 29475237 PMC: 5900376. DOI: 10.30773/pi.2017.06.19.

References

Nelson B, Yung A . Can clinicians predict psychosis in an ultra high risk group?. Aust N Z J Psychiatry. 2010; 44(7):625-30. DOI: 10.3109/00048671003620210. View

Cannon T, Cadenhead K, Cornblatt B, Woods S, Addington J, Walker E . Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008; 65(1):28-37. PMC: 3065347. DOI: 10.1001/archgenpsychiatry.2007.3. View

Corcoran C, First M, Cornblatt B . The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophr Res. 2010; 120(1-3):16-22. PMC: 2923037. DOI: 10.1016/j.schres.2010.03.018. View

Yung A, Phillips L, Yuen H, Francey S, McFarlane C, Hallgren M . Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res. 2002; 60(1):21-32. DOI: 10.1016/s0920-9964(02)00167-6. View

Amminger G, Schafer M, Papageorgiou K, Klier C, Cotton S, Harrigan S . Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010; 67(2):146-54. DOI: 10.1001/archgenpsychiatry.2009.192. View

Morrison A, French P, Parker S, Roberts M, Stevens H, Bentall R . Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull. 2006; 33(3):682-7. PMC: 2526150. DOI: 10.1093/schbul/sbl042. View

Carpenter W . Anticipating DSM-V: should psychosis risk become a diagnostic class?. Schizophr Bull. 2009; 35(5):841-3. PMC: 2728821. DOI: 10.1093/schbul/sbp071. View

McGlashan T, Zipursky R, Perkins D, Addington J, Miller T, Woods S . Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006; 163(5):790-9. DOI: 10.1176/ajp.2006.163.5.790. View

. International clinical practice guidelines for early psychosis. Br J Psychiatry Suppl. 2005; 48:s120-4. DOI: 10.1192/bjp.187.48.s120. View

10.

Yung A, Yuen H, McGorry P, Phillips L, Kelly D, DellOlio M . Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005; 39(11-12):964-71. DOI: 10.1080/j.1440-1614.2005.01714.x. View

11.

Nikula M, Gissler M, Jormanainen V, Sevon T, Hemminki E . Sexual behaviour and lifestyles of young men in Finland, 1998-2005. Cross-sectional survey of military conscripts. Eur J Contracept Reprod Health Care. 2009; 14(1):17-26. DOI: 10.1080/13625180802635654. View

12.

Bechdolf A, Pukrop R, Kohn D, Tschinkel S, Veith V, Schultze-Lutter F . Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res. 2005; 79(1):137-43. DOI: 10.1016/j.schres.2005.06.008. View

13.

Lindstrom M, Mohseni M . Social capital, political trust and self-reported psychological health: a population-based study. Soc Sci Med. 2008; 68(3):436-43. DOI: 10.1016/j.socscimed.2008.11.004. View

14.

Yung A, Nelson B, Thompson A, Wood S . The psychosis threshold in Ultra High Risk (prodromal) research: is it valid?. Schizophr Res. 2010; 120(1-3):1-6. DOI: 10.1016/j.schres.2010.03.014. View

15.

Klosterkotter J . Indicated prevention of schizophrenia. Dtsch Arztebl Int. 2009; 105(30):532-9. PMC: 2696964. DOI: 10.3238/arztebl.2008.0532. View

16.

Leonard K, Masatu M . The use of direct clinician observation and vignettes for health services quality evaluation in developing countries. Soc Sci Med. 2005; 61(9):1944-51. DOI: 10.1016/j.socscimed.2005.03.043. View

17.

Miller T, McGlashan T, Rosen J, Cadenhead K, Cannon T, Ventura J . Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2004; 29(4):703-15. DOI: 10.1093/oxfordjournals.schbul.a007040. View

18.

Klosterkotter J, Hellmich M, Steinmeyer E, Schultze-Lutter F . Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001; 58(2):158-64. DOI: 10.1001/archpsyc.58.2.158. View

19.

Fihn S . The quest to quantify quality. JAMA. 2001; 283(13):1740-2. DOI: 10.1001/jama.283.13.1740. View

20.

McGorry P, Nelson B, Amminger G, Bechdolf A, Francey S, Berger G . Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009; 70(9):1206-12. DOI: 10.4088/JCP.08r04472. View